benzyl (4-(dimethoxymethyl)pyrimidin-2-yl)carbamate | 1312764-25-2

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 英文名称: benzyl (4-(dimethoxymethyl)pyrimidin-2-yl)carbamate
• 英文别名: benzyl N-[4-(dimethoxymethyl)pyrimidin-2-yl]carbamate
• CAS: 1312764-25-2
• 化学式: C₁₅H₁₇N₃O₄
• 分子量: 303.318
• InChiKey: GODMXUDPCHUAFA-UHFFFAOYSA-N

物化性质

• 密度：
  1.270±0.06 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  1.3
• 重原子数：
  22
• 可旋转键数：
  7
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.27
• 拓扑面积：
  82.6
• 氢给体数：
  1
• 氢受体数：
  6

反应信息

• 作为反应物：
  描述：

  benzyl (4-(dimethoxymethyl)pyrimidin-2-yl)carbamate 在 盐酸 、 potassium permanganate 、 硫酸 作用下， 以 水 、 二甲基亚砜 为溶剂， 反应 35.0h， 生成 methyl 2-(((benzyloxy)carbonyl)amino)pyrimidine-4-carboxylate
  参考文献：
  名称：

  Two new approaches towards the synthesis of annomontine using Pictet–Spengler and aza-Diels–Alder reactions

  摘要：

  Two new routes were established for the synthesis of biologically active natural product annomontine utilizing Pictet-Spengler and aza-Diels-Alder reactions as key steps. (C) 2013 Elsevier Ltd. All rights reserved.

  DOI：

  10.1016/j.tetlet.2013.05.026
• 作为产物：
  描述：

  1,1-二甲氧基丙酮 在 碳酸氢钠 作用下， 以 乙醇 、 水 、 N,N-二甲基甲酰胺 为溶剂， 反应 63.25h， 生成 benzyl (4-(dimethoxymethyl)pyrimidin-2-yl)carbamate
  参考文献：
  名称：

  Two new approaches towards the synthesis of annomontine using Pictet–Spengler and aza-Diels–Alder reactions

  摘要：

  Two new routes were established for the synthesis of biologically active natural product annomontine utilizing Pictet-Spengler and aza-Diels-Alder reactions as key steps. (C) 2013 Elsevier Ltd. All rights reserved.

  DOI：

  10.1016/j.tetlet.2013.05.026

文献信息

• [EN] AMINO-HETEROARYL DERIVATIVES AS HCN BLOCKERS<br/>[FR] DÉRIVÉS AMINO-HÉTÉROARYLE EN TANT QUE COMPOSÉS BLOQUANT HCN
  申请人：ORGANON NV

  公开号：WO2011076723A1

  公开（公告）日：2011-06-30

  The invention relates to amino-heteroaryl derivatives having the general Formula I or a pharmaceutically acceptable salt thereof, to pharmaceutical compositions comprising the same, as well as to the use of these derivatives for the treatment of pain, such as neuropathic pain or inflammatory pain.

  这项发明涉及具有一般化学式I或其药用可接受盐的氨基-杂环芳基衍生物，以及包含这些衍生物的药物组合物，以及利用这些衍生物治疗疼痛，如神经病性疼痛或炎症性疼痛。
• [EN] COMPOUNDS FOR THE TREATMENT OF RESPIRATORY DISEASES<br/>[FR] COMPOSÉS POUR TRAITER DES MALADIES RESPIRATOIRES
  申请人：UNIV MELBOURNE

  公开号：WO2018201192A1

  公开（公告）日：2018-11-08

  The present invention relates to new compounds that are useful in the prevention or treatment of respiratory diseases, such as asthma, to the preparation of the compounds, and to compositions including the compounds. The present invention also relates to the use of the compounds, as well as compositions including the compounds, in treating or preventing respiratory diseases.

  本发明涉及新化合物，可用于预防或治疗呼吸道疾病，如哮喘，以及制备这些化合物和包括这些化合物的组合物。本发明还涉及利用这些化合物以及包括这些化合物的组合物来治疗或预防呼吸道疾病。
• [EN] COMPOUNDS AND COMPOSITIONS FOR THE TREATMENT OF RESPIRATORY DISEASES<br/>[FR] COMPOSÉS ET COMPOSITIONS POUR LE TRAITEMENT DE MALADIES RESPIRATOIRES
  申请人：UNIV MELBOURNE

  公开号：WO2020093097A1

  公开（公告）日：2020-05-14

  The present invention relates to new compounds that are useful in the prevention or treatment of respiratory diseases, such as asthma, acute and chronic inflammatory conditions, and fibrotic diseases or conditions in which fibrosis contributes to the pathology of the condition. The invention also relates to the preparation of the compounds, and to compositions including the compounds. The present invention also relates to the use of the compounds, as well as compositions including the compounds, in treating or preventing respiratory diseases, acute and chronic inflammatory conditions, and fibrotic diseases or conditions in which fibrosis contributes to the pathology of the condition.

  本发明涉及新化合物，可用于预防或治疗呼吸道疾病，如哮喘、急性和慢性炎症病症，以及纤维化疾病或病症，在这些疾病或病症中，纤维化导致病理病变。该发明还涉及这些化合物的制备，以及包括这些化合物的组合物。本发明还涉及在治疗或预防呼吸道疾病、急性和慢性炎症病症，以及纤维化疾病或病症中使用这些化合物，以及包括这些化合物的组合物。
• AMINO-HETEROARYL DERIVATIVES AS HCN BLOCKERS
  申请人：Grove Simon James Anthony

  公开号：US20120264728A1

  公开（公告）日：2012-10-18

  The invention relates to amino-heteroaryl derivatives having the general Formula I or a pharmaceutically acceptable salt thereof, to pharmaceutical compositions comprising the same, as well as to the use of these derivatives for the treatment of pain, such as neuropathic pain or inflammatory pain.

  本发明涉及具有一般式I或其药学上可接受的盐的氨基-杂芳基衍生物，以及包含其的制药组合物，以及使用这些衍生物治疗疼痛，例如神经病性疼痛或炎症性疼痛的用途。
• Amino-heteroaryl derivatives as HCN blockers
  申请人：Merck Sharp & Dohme B.V.

  公开号：EP2516397B1

  公开（公告）日：2016-07-13